These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

698 related items for PubMed ID: 29066371

  • 1. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.
    La Mura V, Braham S, Tosetti G, Branchi F, Bitto N, Moia M, Fracanzani AL, Colombo M, Tripodi A, Primignani M.
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1146-1152.e4. PubMed ID: 29066371
    [Abstract] [Full Text] [Related]

  • 2. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Noronha Ferreira C, Reis D, Cortez-Pinto H, Tato Marinho R, Gonçalves A, Palma S, Leite I, Rodrigues T, Pedro AJ, Alexandrino P, Serejo F, Sobral Dias M, Ferreira P, Vasconcelos M, Damião F, Xavier Brito L, Baldaia C, Fatela N, Ramalho F, Velosa J.
    Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anticoagulation Therapy for Portal Vein Thrombosis in Patients with Cirrhosis in a Tertiary Center Experience.
    Florescu MM, Costache A, Iacob SM, Pietrareanu C, Ester C, Cerban R, Dumitru R, Grasu M, Lupescu I, Gheorghe L.
    J Gastrointestin Liver Dis; 2021 Sep 21; 30(3):374-379. PubMed ID: 34551038
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.
    Delgado MG, Seijo S, Yepes I, Achécar L, Catalina MV, García-Criado A, Abraldes JG, de la Peña J, Bañares R, Albillos A, Bosch J, García-Pagán JC.
    Clin Gastroenterol Hepatol; 2012 Jul 21; 10(7):776-83. PubMed ID: 22289875
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.
    Wang L, Guo X, Xu X, De Stefano V, Plessier A, Noronha Ferreira C, Qi X.
    Adv Ther; 2021 Jan 21; 38(1):495-520. PubMed ID: 33155180
    [Abstract] [Full Text] [Related]

  • 9. Analysis of factors related to recanalization of portal vein thrombosis in liver cirrhosis: a retrospective cohort study.
    Shi Y, Feng W, Cai J, Wang Z, Pu Y, Mao W, Zhan K, Chen D.
    BMC Gastroenterol; 2024 Jul 13; 24(1):224. PubMed ID: 39003447
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
    Pettinari I, Vukotic R, Stefanescu H, Pecorelli A, Morelli M, Grigoras C, Sparchez Z, Andreone P, Piscaglia F, BO-LIVES (BOlogna LIVEr vascular Studies).
    Am J Gastroenterol; 2019 Feb 13; 114(2):258-266. PubMed ID: 30538290
    [Abstract] [Full Text] [Related]

  • 12. Impact of anticoagulation therapy on outcomes in patients with cirrhosis and portal vein thrombosis: A large-scale retrospective cohort study.
    Niu C, Zhang J, Himal K, Zhu K, Zachary T, Verghese B, Jadhav N, Okolo PI, Daglilar E, Kouides P.
    Thromb Res; 2024 Sep 13; 241():109103. PubMed ID: 39067278
    [Abstract] [Full Text] [Related]

  • 13. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M, Zhu K, Huang W, Meng X, He K, Zhou B, Guo Y, Chen J, Shan H.
    J Vasc Interv Radiol; 2013 Dec 13; 24(12):1808-16. PubMed ID: 24099787
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis.
    Zhou H, Wu M, Yu S, Xia H, Yu W, Huang K, Chen Y.
    BMC Gastroenterol; 2023 Sep 25; 23(1):329. PubMed ID: 37749527
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis.
    Gao Y, Liu H, Tang F, Zhang X, Li F, Ye Q, Yuan H, Lv H, Han T.
    Clin Res Hepatol Gastroenterol; 2021 Mar 25; 45(2):101649. PubMed ID: 33601064
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.